Amyloid Solution
Signal active
Investment Firm
Overview
Amyloid Solution is a developer of therapy intended to overcome Alzheimer by developing modifying treatments. The company focuses on pathophysiological events related to disease progression and its underlying mechanism to find novel therapeutics, enabling clients with the best solution for Alzheimer disease.
Highlights
Founded
2017
Industry
Biotechnology
Employees
11-50
Investment
1
Lead Investment
0
Exits
undefined
Stages
Seed
Investor Type
N/A
Location
Asia
Contact Information
Social
Profile Resume
Amyloid Solution, established in 2017 and headquartered in Asia., specializes in Seed investments across Biotechnology, Artificial Intelligence (AI), Machine Learning. Their recent investments include Deargen. The highest investment round they participated in was $31.8M. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Employees
N/A
Investment portfolio
Amyloid Solution has made 1 investments. Their most recent investment was on Oct 26, 2020, when Deargen raised $2.6M.
investments
1
Diversity investments
0
Lead investments
0
Number of exits
undefined
Investments
1
| Annouced Date | Organization Name | Industry | Money Raised |
|---|---|---|---|
| Oct 26, 2020 | Deargen | Biotechnology | 2.6M |
Exits
0
Funding Timeline
Funding rounds
1
Investors
18
Funds
0
Funding Rounds
1
Amyloid Solution has raised 1 rounds. Their latest funding was raised on Oct 26, 2020 from a Seed Round - Deargen round.
| Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
|---|---|---|---|---|
| Oct 26, 2020 | Seed Round - Deargen | - | 2.6M | - |
Investors
19
Amyloid Solution is funded by 19 investor(s). SK Securities and POSCO CAPITAL Kantor are the most recent investors.
| Investor Name | Lead Investor | Funding Round | Money Raised |
|---|---|---|---|
IBK Capital | No | Series C - Amyloid Solution | 3.6M |
KOREA INVESTMENT & SECURITIES | No | Series C - Amyloid Solution | 3.6M |
POSCO CAPITAL | No | Series C - Amyloid Solution | 3.6M |
SK Securities | No | Series C - Amyloid Solution | 3.6M |
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
| Annouced Date | Fund Name | Money Raised |
|---|---|---|
| May 10, 2013 | OTPPLESS | 1.0M |
| May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
Recent Activity
There is no recent news or activity for this profile.